Narrow Band Imaging Can Reduce Bladder Tumor Recurrence
|
By MedImaging International staff writers Posted on 09 Jun 2016 |
|
Image: A comparison of white light to narrow band imaging (Photo courtesy of Olympus Medical Systems).
A new study concludes that narrow band imaging (NBI) technology can significantly reduce the risk of bladder tumor recurrence.
Researchers at Harasanshin Hospital (Fukuoka, Japan), the University of Birmingham (United Kingdom), and other institutions conducted a randomized study in 965 patients with primary non–muscle-invasive bladder cancer following transurethral resection of bladder tumor (TURBT). The patients were randomized to NBI compared to white light (WL) guidance, the established imaging modality for TURBT. The primary outcome was 12-month bladder tumor recurrence rates.
The results showed WL-assisted TURBT recurrence rates of 27.1% and NBI-assisted TURBT recurrence rates of 25.4%. In patients at low risk for disease recurrence, recurrence rates at 12 months were significantly higher in the WL group (27.3%) than in the NBI group (5.6%). Although TURBT took longer on average with NBI plus WL compared with WL alone, lesions were significantly more often visible. The study was published on April 24, 2106, in European Urology.
“Narrow band imaging makes it easier to identify bladder tumors. It can detect small bladder tumors that might otherwise by overlooked by more conventional 'white light' cystoscopy,” said study co-author Richard Bryan, MD, PhD, of the University of Birmingham. “My colleague, Mike Wallace, and I immediately saw the potential of this technology. Now this potential has been confirmed by a large international randomized controlled trial, and the results can only be good news for bladder cancer patients worldwide.”
NBI technology, developed by Olympus Medical Systems (Tokyo, Japan), is a powerful optical enhancement technology that improves the visibility of blood vessels and other structures on the bladder mucosa by illuminating them with two specific wavelengths strongly absorbed by hemoglobin. The shorter wavelength (415 nm) only penetrates the top layer of the mucosa, and shows up as brown on the NBI image, The longer wavelength (540 nm) is absorbed by blood vessels located deeper within the mucosal layer, and appears cyan on the NBI image.
Related Links:
Harasanshin Hospital
University of Birmingham
Olympus Medical Systems
Researchers at Harasanshin Hospital (Fukuoka, Japan), the University of Birmingham (United Kingdom), and other institutions conducted a randomized study in 965 patients with primary non–muscle-invasive bladder cancer following transurethral resection of bladder tumor (TURBT). The patients were randomized to NBI compared to white light (WL) guidance, the established imaging modality for TURBT. The primary outcome was 12-month bladder tumor recurrence rates.
The results showed WL-assisted TURBT recurrence rates of 27.1% and NBI-assisted TURBT recurrence rates of 25.4%. In patients at low risk for disease recurrence, recurrence rates at 12 months were significantly higher in the WL group (27.3%) than in the NBI group (5.6%). Although TURBT took longer on average with NBI plus WL compared with WL alone, lesions were significantly more often visible. The study was published on April 24, 2106, in European Urology.
“Narrow band imaging makes it easier to identify bladder tumors. It can detect small bladder tumors that might otherwise by overlooked by more conventional 'white light' cystoscopy,” said study co-author Richard Bryan, MD, PhD, of the University of Birmingham. “My colleague, Mike Wallace, and I immediately saw the potential of this technology. Now this potential has been confirmed by a large international randomized controlled trial, and the results can only be good news for bladder cancer patients worldwide.”
NBI technology, developed by Olympus Medical Systems (Tokyo, Japan), is a powerful optical enhancement technology that improves the visibility of blood vessels and other structures on the bladder mucosa by illuminating them with two specific wavelengths strongly absorbed by hemoglobin. The shorter wavelength (415 nm) only penetrates the top layer of the mucosa, and shows up as brown on the NBI image, The longer wavelength (540 nm) is absorbed by blood vessels located deeper within the mucosal layer, and appears cyan on the NBI image.
Related Links:
Harasanshin Hospital
University of Birmingham
Olympus Medical Systems
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Ultrasound Needle Guide
Ultra-Pro II
New
Remote Controlled Digital Radiography and Fluoroscopy System
Eco Track-DRF - MARS 50/MARS50+/MARS 65/MARS 80
New
Wireless Handheld Ultrasound System
TE Air
Latest Radiography News
- Novel Breast Imaging System Proves As Effective As Mammography
- AI Assistance Improves Breast-Cancer Screening by Reducing False Positives
- AI Could Boost Clinical Adoption of Chest DDR
- 3D Mammography Almost Halves Breast Cancer Incidence between Two Screening Tests
- AI Model Predicts 5-Year Breast Cancer Risk from Mammograms
- Deep Learning Framework Detects Fractures in X-Ray Images With 99% Accuracy
- Direct AI-Based Medical X-Ray Imaging System a Paradigm-Shift from Conventional DR and CT
- Chest X-Ray AI Solution Automatically Identifies, Categorizes and Highlights Suspicious Areas
- AI Diagnoses Wrist Fractures As Well As Radiologists
- Annual Mammography Beginning At 40 Cuts Breast Cancer Mortality By 42%
- 3D Human GPS Powered By Light Paves Way for Radiation-Free Minimally-Invasive Surgery
- Novel AI Technology to Revolutionize Cancer Detection in Dense Breasts
- AI Solution Provides Radiologists with 'Second Pair' Of Eyes to Detect Breast Cancers
- AI Helps General Radiologists Achieve Specialist-Level Performance in Interpreting Mammograms
- Novel Imaging Technique Could Transform Breast Cancer Detection
- Computer Program Combines AI and Heat-Imaging Technology for Early Breast Cancer Detection
Channels
MRI
view channel
Low-Cost Whole-Body MRI Device Combined with AI Generates High-Quality Results
Magnetic Resonance Imaging (MRI) has significantly transformed healthcare, providing a noninvasive, radiation-free method for detailed imaging. It is especially promising for the future of medical diagnosis... Read more
World's First Whole-Body Ultra-High Field MRI Officially Comes To Market
The world's first whole-body ultra-high field (UHF) MRI has officially come to market, marking a remarkable advancement in diagnostic radiology. United Imaging (Shanghai, China) has secured clearance from the U.... Read more
Ultrasound
view channel.jpg "Image: CAM figures of testing images (Photo courtesy of SPJ; DOI:10.34133/research.0319)")
Diagnostic System Automatically Analyzes TTE Images to Identify Congenital Heart Disease
Congenital heart disease (CHD) is one of the most prevalent congenital anomalies worldwide, presenting substantial health and financial challenges for affected patients. Early detection and treatment of... Read more
Super-Resolution Imaging Technique Could Improve Evaluation of Cardiac Conditions
The heart depends on efficient blood circulation to pump blood throughout the body, delivering oxygen to tissues and removing carbon dioxide and waste. Yet, when heart vessels are damaged, it can disrupt... Read more
First AI-Powered POC Ultrasound Diagnostic Solution Helps Prioritize Cases Based On Severity
Ultrasound scans are essential for identifying and diagnosing various medical conditions, but often, patients must wait weeks or months for results due to a shortage of qualified medical professionals... Read more
Nuclear Medicine
view channel
New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy
Immunotherapies, such as immune checkpoint blockade (ICB), have shown promising clinical results in treating melanoma, non-small cell lung cancer, and other tumor types. However, the effectiveness of these... Read more![Image: Whole-body maximum-intensity projections over time after [68Ga]Ga-DPI-4452 administration (Photo courtesy of SNMMI)](https://globetechcdn.com/mobile_medicalimaging/images/stories/articles/article_images/2024-05-09/JNM May 2024 Hofman.jpg "Image: Whole-body maximum-intensity projections over time after [68Ga]Ga-DPI-4452 administration (Photo courtesy of SNMMI)"){kind=small}
New PET Agent Rapidly and Accurately Visualizes Lesions in Clear Cell Renal Cell Carcinoma Patients
Clear cell renal cell cancer (ccRCC) represents 70-80% of renal cell carcinoma cases. While localized disease can be effectively treated with surgery and ablative therapies, one-third of patients either... Read more
New Imaging Technique Monitors Inflammation Disorders without Radiation Exposure
Imaging inflammation using traditional radiological techniques presents significant challenges, including radiation exposure, poor image quality, high costs, and invasive procedures. Now, new contrast... Read more
New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access
The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read moreGeneral/Advanced Imaging
view channel
Bone Density Test Uses Existing CT Images to Predict Fractures
Osteoporotic fractures are not only devastating and deadly, especially hip fractures, but also impose significant costs. They rank among the top chronic diseases in terms of disability-adjusted life years... Read more
AI Predicts Cardiac Risk and Mortality from Routine Chest CT Scans
Heart disease remains the leading cause of death and is largely preventable, yet many individuals are unaware of their risk until it becomes severe. Early detection through screening can reveal heart issues,... Read more
Imaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more
Industry News
view channel
Hologic Acquires UK-Based Breast Surgical Guidance Company Endomagnetics Ltd.
Hologic, Inc. (Marlborough, MA, USA) has entered into a definitive agreement to acquire Endomagnetics Ltd. (Cambridge, UK), a privately held developer of breast cancer surgery technologies, for approximately... Read more
Bayer and Google Partner on New AI Product for Radiologists
Medical imaging data comprises around 90% of all healthcare data, and it is a highly complex and rich clinical data modality and serves as a vital tool for diagnosing patients. Each year, billions of medical... Read more
